NASDAQ: ANIP
Ani Pharmaceuticals Inc Stock Ownership - Who owns Ani Pharmaceuticals?

Insider buying vs selling

Have Ani Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Nikhil LalwaniCEO;Pres2026-09-155,400$71.00
$383.40kSell
Meredith CookCLO;Sec;SVP2026-09-14500$70.79
$35.40kSell
Jeanne ThomaDirector2026-09-111,000$71.53
$71.53kSell
Stephen P. CareyCFO;SVP2026-08-312,850$72.80
$207.48kSell
Nikhil LalwaniCEO;Pres2026-08-255,400$74.30
$401.22kSell
Meredith CookCLO;Sec;SVP2026-08-13500$75.48
$37.74kSell
Ori GutwergSVP2026-08-103,162$77.00
$243.47kSell
Stephen P. CareyCFO;SVP2026-07-292,850$81.36
$231.88kSell
Meredith CookCLO;Sec;SVP2026-07-182,466$79.20
$195.31kSell
Meredith CookCLO;Sec;SVP2026-07-13500$81.84
$40.92kSell

1 of 10

ANIP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ANIP insiders and whales buy or sell their stock.

ANIP Shareholders

What type of owners hold Ani Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Meridian Venture Partners II LP81.57%18,737,728$1.39BInsider
Robert E. Brown Jr.73.87%16,967,490$1.26BInsider
Ross J. Mangano25.22%5,792,084$428.61MInsider
Tracy Marshbanks10.05%2,308,568$170.83MInsider
Victor A. Morgenstern4.07%936,014$69.27MInsider
Muthusamy Shanmugam2.36%542,976$40.18MInsider
Nikhil Lalwani1.48%339,089$25.09MInsider
Daniel Raynor1.31%300,113$22.21MInsider
Stephen M. Simes1.17%269,146$19.92MInsider
Chad Gassert1.02%233,406$17.27MInsider

1 of 3

ANIP vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ANIP0.05%99.95%Net SellingNet Selling
ETON0.07%31.63%Net SellingNet Selling
PAHC0.05%62.64%Net SellingNet Selling
ALVO0.01%0.00%
BHC0.06%63.23%Net BuyingNet Selling

Ani Pharmaceuticals Stock Ownership FAQ

Who owns Ani Pharmaceuticals?

Ani Pharmaceuticals (NASDAQ: ANIP) is owned by 0.10% institutional shareholders, 208.63% Ani Pharmaceuticals insiders, and 0.00% retail investors. Meridian Venture Partners II LP is the largest individual Ani Pharmaceuticals shareholder, owning 18.74M shares representing 81.57% of the company. Meridian Venture Partners II LP's Ani Pharmaceuticals shares are currently valued at $1.39B.

If you're new to stock investing, here's how to buy Ani Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.